PTPA activates protein phosphatase-2A through reducing its phosphorylation at tyrosine-307 with upregulation of protein tyrosine phosphatase 1B

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 5, 2013, Pages 1235-1243

  Luo, Yu ^a   Nie, Yun Juan ^a   Shi, Hai Rong ^a   Ni, Zhong Fei ^a   Wang, Qun ^a   Wang, Jian Zhi ^a   Liu, Gong Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alzheimer disease; Phosphorylation; Protein phosphatase 2A; Protein phosphatase 2A phosphatase activator; Protein tyrosine phosphatase 1B; Tau

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ENZYME ACTIVATOR; MESSENGER RNA; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOTYROSYL PHOSPHATASE ACTIVATOR; PROTEIN TYROSINE PHOSPHATASE 1B; TAU PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; DOWN-REGULATION; HUMANS; MICE; MICE, TRANSGENIC; NEURONS; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; TAU PROTEINS; TYROSINE; UP-REGULATION;

EID: 84875245784     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.02.005     Document Type: Article

References (43)

1. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., Wisniewski H.M. Microtubule-associated protein tau: a component of Alzheimer paired helical filament. J. Biol. Chem. 1986, 261:6084-6089.
2. Lee V.M., Balin B.J., Otvos L.J., Trojanowski J.Q. A68: a major subunit of the paired helical filaments and derivatized forms of normal tau. Science 1991, 251:675-678.
3. Hanger D.P., Seereeram A., Noble W. Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease. Expert Rev. Neurother. 2009, 9:1647-1666.
4. Wang J.Z., Grundke-Iqbal I., Iqbal K. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur. J. Neurosci. 2007, 25:59-68.
5. Liu F., Grundke-Iqbal I., Iqbal K., Gong C.X. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 2005, 22:1942-1950.
6. Gong C.X., Singh T.J., Grundke-Iqbal I., Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 1993, 61:921-927.
7. Cohen P. The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 1989, 58:453-508.
8. Wera S., Hemmings B.A. Serine/threonine protein phosphatases. Biochem. J. 1995, 311:17-29.
9. Li M., Guo H., Damuni Z. Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry 1995, 34:1988-1996.
10. Lee J., Stock J. Protein phosphatase 2A catalytic subunit is methyl-esterified at its carboxyl terminus by a novel methyltransferase. J. Biol. Chem. 1993, 268:19192-19195.
11. Li M., Damuni Z. Okadaic acid and microcystin-LR directly inhibit the methylation of protein phosphatase 2A by its specific methyltransferase. Biochem. Biophys. Res. Commun. 1994, 202:1023-1030.
12. Favre B., Zolnierowicz S., Turowski P., Hemmings B.A. The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. J. Biol. Chem. 1994, 269:16311-16317.
13. Xie H., Clarke S. Protein phosphatase 2A is reversibly modified by methyl esterification at its C-terminal leucine residue in bovine brain. J. Biol. Chem. 1994, 269:1981-1984.
14. Chen J., Martin B.L., Brautigan D.L. Regulation of protein serine threonine phosphatase type-2A by tyrosine phosphorylation. Science 1992, 257:1261-1264.
15. Sontag E., Luangpirom A., Hladik C., Mudrak I., Ogrisrd E., Speciale S., White C.L. Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J. Neuropathol. Exp. Neurol. 2004, 63:287-301.
16. Sontag E., Hladik C., Montgomery L., Luangpirom A., Mudrak I., Ogris E., White C.L. Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J. Neuropathol. Exp. Neurol. 2004, 63:1080-1091.
17. Liu G.P., Zhang Y., Yao X.Q., Zhang C.E., Fang J., Wang Q., Wang J.Z. Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms. Neurobiol. Aging 2008, 29:1348-1358.
18. Yao X.Q., Zhang X.X., Yin Y.Y., Liu B., Luo D.J., Liu D., Chen N.N., Ni Z.F., Wang X., Wang Q., Wang J.Z., Liu G.P. Glycogen synthase kinase-3β regulates tyrosine-307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src. Biochem. J. 2011, 437:335-344.
19. Yao X.Q., Li X.C., Zhang X.X., Yin Y.Y., Liu B., Luo D.J., Wang Q., Wang J.Z., Liu G.P. Glycogen synthase kinase-3β regulates leucine-309 demethylation of protein phosphatase-2A via PPMT1 and PME-1. FEBS Lett. 2012, 586:2522-2528.
20. Cayla X., Goris J., Hermann J., Hendrix P., Ozon R., Merlevede W. Isolation and characterization of a tyrosyl phosphatase activator from rabbit skeletal muscle and Xenopus laevis oocytes. Biochemistry 1990, 29:658-667.
21. Van Hoof C., Aly M.S., Garcia A., Cayla X., Cassiman J.J., Merlevede W., Goris J. Structure and chromosomal localization of the human gene of the phosphotyrosyl phosphatase activator (PTPA) protein phosphatase 2A. Genomics 1995, 28:261-272.
22. Janssens V., Van Hoof C., Martens E., De Baere I., Merlevede W., Gorris J. Identification and characterization of alternative splice products encoded by the human phosphotyrosyl phosphatase activator gene. Eur. J. Biochem. 2000, 267:4406-4413.
23. Janssens V., Van Hoof C., De Baere I., Merlevede W., Gorris J. Functional analysis of the promoter region of the human phosphotyrosine phosphatase activator gene: Yin Yang 1 is essential for core promoter activity. Biochem. J. 1999, 344:755-763.
24. Janssens V., Van Hoof C., Martens E., De Baere I., Merlevede W., Gorris J. The phosphotyrosyl phosphatase activator gene is a novel p53 target gene. J. Biol. Chem. 2000, 275:20488-20495.
25. Cayla X., Van Hoof C., Bosch M., Waelkens E., Vandekerckhove J., Peeters B., Merlevede W., Goris J. Molecular cloning, expression and characterization of PTPA, a protein that activates the tyrosyl phosphatase activity of protein phosphatase 2A. J. Biol. Chem. 1994, 269:15668-15675.
26. Van Hoof C., Janssens V., Dinishiotu A., Merlevede W., Goris J. Functional analysis of conserved domains in the phosphotyrosyl phosphatase activator: molecular cloning of the homologues from Drosophila melanogaster and Saccharomyces cerevisiae. Biochemistry 1998, 37:12899-12908.
27. Fellner T., Lackner D.H., Hombauer H., Piribauer P., Mudrak I., Zaragoza K., Juno C., Ogris E. A novel and essential mechanism determining specificity and activity of protein phosphatase 2A (PP2A) in vivo. Genes Dev. 2003, 17:2138-2150.
28. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2000, 411:494-498.
29. Wang J.Z., Grundke-Iqbal I., Iqbal K. (Restoration of biological activity of Alzheimer abnormally phosphorylated τ by dephosphorylation with protein phosphatase-2A, -2B and -1. Mol. Brain Res. 1996, 38:200-208.
30. Yamamoto H., Hasegawa M., Ono T., Tashima K., Ihara Y., Miyamoto E. Dephosphorylation of fetal-tau and paired helical filament-tau by protein phosphatase 1 and 2A and calcineurin. J. Biochem. 1995, 118:1224-1231.
31. Van Hoof C., Cayla X., Bosch M., Merlevede W., Goris J. The phosphotyrosyl phosphatase activator of protein phosphatase 2A. A novel purification method, immunological and enzymic characterization. Eur. J. Biochem. 1994, 226:899-907.
32. Jordens J., Janssens V., Longin S., Stevens I., Mrtens E., Bultynck G., Engelborghs Y., Lescrinier E., Waelkens E., Goris J., Van Hoof C. The protein phosphatase 2A phosphatase activator is a novel peptidyl-prolyl cis/trans-isomerase. J. Biol. Chem. 2006, 281:6349-6357.
33. Chao Y., Xing Y., Chen Y., Xu Y., Lin Z., Li Z., Jeffrey P.D., Stock J.B., Shi Y. Structure and mechanism of the phosphotyrosyl phosphatase activator. Mol. Cell 2006, 23:535-546.
34. Longin S., Jordens J., Martens E., Stevens I., Janssens V., Rondelez E., De Baere I., Derua R., Waelkens E., Goris J., Van Hoof C. An inactive protein phosphatase 2A population is associated with methylesterase and can be re-activated by the phosphotyrosyl phosphatase activator. Biochem. J. 2004, 380:111-119.
35. Van Hoof C., Martens E., Longin S., Jordens J., Stevens I., Janssens V., Goris J. Specific interactions of PP2A and PP2A-like phosphatases with the yeast PTPA homologues, Ypa1 and Ypa2. Biochem. J. 2005, 386:93-102.
36. Jordens J., Janssens V., Longin S., Stevens I., Martens E., Bultynck G., Engelborghs Y., Lescrinier E., Waelkens E., Goris J., Van Hoof C. The PP2A phosphatase activator (PTPA) is a novel peptidyl-prolyl cis/trans isomerase. J. Biol. Chem. 2006, 281:6349-6357.
37. Chen J., Parsons S., Brautigan D.L. Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. J. Biol. Chem. 1994, 269:7957-7962.
38. Shimizu S., Ugi S., Maegawa H., Egawa K., Nishio Y., Yoshizaki T., Shi K., Nagai Y., Morino K., Nemoto K., Nakamura T., Bryer-Ash M., Kashiwagi A. Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J. Biol. Chem. 2003, 278:43095-43101.
39. Yokoyama N., Miller W.T. Inhibition of Src by direct interaction with protein phosphatase 2A. FEBS Lett. 2001, 505:460-464.
40. Azam S., Drobetsky E., Ramotar D. Overexpression of the cis/trans isomerase PTPA triggers caspase 3-dependent apoptosis. Apoptosis 2007, 12:1243-1255.
41. Ortiz C., Caja L., Bertran E., Gonzalez-Rodriguez Á., Valverde Á.M., Fabregat I., Sancho P. Protein-tyrosine phosphatase 1B (PTP1B) deficiency confers resistance to transforming growth factor-β (TGF-β)-induced suppressor effects in hepatocytes. J. Biol. Chem. 2012, 287:15263-15274.
42. Gagarina V., Gabay O., Dvir-Ginzberg M., Lee E.J., Brady J.K., Quon M.J., Hall D.J. SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum. 2010, 62:1383-1392.
43. Miranda S., González-Rodríguez A., Revuelta-Cervantes J., Rondinone C.M., Valverde A.M. Beneficial effects of PTP1B deficiency on brown adipocyte differentiation and protection against apoptosis induced by pro- and anti-inflammatory stimuli. Cell. Signal. 2010, 22:645-659.